NAT10 and familial pancreatic carcinoma: These results demonstrate that NAT10 stabilizes ETS2 mRNA by catalyzing ac4C acetylation, thereby regulating PD-L1 expression and contributing to the immunosuppressive microenvironment of pancreatic cancer.